Evidence map›Paper›PMID 28296354›Full record

ArticleCPT: pharmacometrics & systems pharmacology2017

CATTLE (CAncer treatment treasury with linked evidence): An integrated knowledge base for personalized oncology research and practice.

E Soysal, H-J Lee, Y Zhang, L-C Huang, X Chen, Q Wei, W Zheng, J T Chang, T Cohen, J Sun and 1 more

Open access · goldAbstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Precision Medicine in Pharmacometrics and Systems Pharmacology.CPT: pharmacometrics & systems pharmacology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

E SoysalUniversity of Texas Health Science Center at Houston, Houston, Texas, USA.
H-J LeeUniversity of Texas Health Science Center at Houston, Houston, Texas, USA.
Y ZhangUniversity of Texas Health Science Center at Houston, Houston, Texas, USA.
L-C HuangUniversity of Texas Health Science Center at Houston, Houston, Texas, USA.
X ChenUniversity of Texas Health Science Center at Houston, Houston, Texas, USA.
Q WeiUniversity of Texas Health Science Center at Houston, Houston, Texas, USA.
W ZhengUniversity of Texas Health Science Center at Houston, Houston, Texas, USA.
J T ChangUniversity of Texas Health Science Center at Houston, Houston, Texas, USA.
T CohenUniversity of Texas Health Science Center at Houston, Houston, Texas, USA.
J SunUniversity of Texas Health Science Center at Houston, Houston, Texas, USA.
H XuUniversity of Texas Health Science Center at Houston, Houston, Texas, USA.
The University of Texas Health Science Center at Houston · US

Funding

Natural language processing for clinical and translational researchR01GM102282 · NIGMS · MAYO CLINIC ROCHESTER · PI LIU, HONGFANG, PAKHOMOV, SERGUEI VS · 2013 to 2016
$2.5M
NIGMS NIH HHS R01 GM102282
6 · The paper itself

Abstract

Despite the existence of various databases cataloging cancer drugs, there is an emerging need to support the development and application of personalized therapies, where an integrated understanding of the clinical factors and drug mechanism of action and its gene targets is necessary. We have developed CATTLE (CAncer Treatment Treasury with Linked Evidence), a comprehensive cancer drug knowledge base providing information across the complete spectrum of the drug life cycle. The CATTLE system collects relevant data from 22 heterogeneous databases, integrates them into a unified model centralized on drugs, and presents comprehensive drug information via an interactive web portal with a download function. A total of 2,323 unique cancer drugs are currently linked to rich information from these databases in CATTLE. Through two use cases, we demonstrate that CATTLE can be used in supporting both research and practice in personalized oncology.

Indexed as

Knowledge BasesAntineoplastic AgentsBiomedical ResearchClinical Trials as TopicDatabases, FactualDrug DiscoveryHumansNeoplasmsPrecision MedicineAntineoplastic Agents

Identifiers

PMID28296354
PMCPMC5351410
OpenAlexW2602506514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.